IRCT2016102713947N5已完成2 期
Effects of intravenous ceftriaxone in neurologic outcome of acute spinalcord injury patients compared with methylprednixolone alone
Road traffic injury prevention research center, Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 17 years 至 60 years（—）
- 性别
- All
入选标准
- •Patients with spinal cord injury from T10 to L2; Patients with age of 17 to 60 ; Frankle grade A to D
- •Exclusion criteria: Patients older or younger than 17-60; Patients with head trauma and GCS score lower than 13; Reaction to Ceftriaxone use; Amp Calcium intake or other drugs with calcium ; First trimester; E grade based on Frankel classification at admission; Spinal cord injury out of T10 to L2
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis. - NDAmyotrophic lateral sclerosis (ALS)MedDRA version: 6.1Level: PTClassification code 10002026EUCTR2007-004165-17-ITAZIENDA OSPEDALIERA PISANA
招募中
不适用
Susceptibility of Ceftriaxone on infectionsCTRI/2022/04/041997Alkem Laboratories
终止
2 期
PROPER Trial of Pain and Inflammation After Knee ArthroscopyMeniscus TearMeniscus LesionCartilage InjuryNCT05149287Austin V Stone5
已完成
不适用
The efficacy and safety evaluation of ceftriaxone and sulbactam combination (1.5 gram) in patients with skin and soft tissue infections: an open label, parallel, randomized, prospective comparative trialSkin and soft tissue infectionsInfections and InfestationsISRCTN76443564Ranbaxy Laboratories Ltd (India)400
终止
不适用
Ceftriaxone in the Management of Bipolar DepressionBipolar DepressionNCT00566111Yale University5